【2h】

MicroRNAs in Human Pituitary Adenomas

机译:人垂体腺瘤中的MicroRNA

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRNAs) are a class of recently identified noncoding RNAs that regulate gene expression at posttranscriptional level. Due to the large number of genes regulated by miRNAs, miRNAs play important roles in many cellular processes. Emerging evidence indicates that miRNAs are dysregulated in pituitary adenomas, a class of intracranial neoplasms which account for 10–15% of diagnosed brain tumors. Deregulated miRNAs and their targets contribute to pituitary adenomas progression and are associated with cell cycle control, apoptosis, invasion, and pharmacological treatment of pituitary adenomas. To provide an overview of miRNAs dysregulation and functions of these miRNAs in pituitary adenoma progression, we summarize the deregulated miRNAs and their targets to shed more light on their potential as therapeutic targets and novel biomarkers.
机译:MicroRNA(miRNA)是一类最近鉴定的非编码RNA,可在转录后水平调控基因表达。由于miRNA调控着大量的基因,miRNA在许多细胞过程中起着重要的作用。新兴证据表明,垂体腺瘤(一种颅内肿瘤)中的miRNA失调,占诊断出的脑肿瘤的10-15%。失调的miRNA及其靶标有助于垂体腺瘤的进展,并与垂体腺瘤的细胞周期控制,细胞凋亡,侵袭和药理治疗有关。为了概述垂体腺瘤进展中miRNA的失调和这些miRNA的功能,我们总结了失调的miRNA及其靶标,以阐明其作为治疗靶标和新型生物标志物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号